Resistin is secreted from macrophages in atheromas and promotes atherosclerosis

Cardiovascular Research

Volumn 69, Issue 1, 2006, Pages 76-85

  Jung, Hye Seung ^a,b   Park, Ki Ho ^b   Cho, Young Min ^a,b   Chung, Sung Soo ^b   Cho, Hyun Ju ^a   Cho, Soo Youn ^a   Kim, Sang Joon ^a   Kim, Seong Yeon ^a   Lee, Hong Kyu ^a   Park, Kyong Soo ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Atherosclerosis; Macrophages; Migration; PAI 1; Resistin

Indexed keywords

CD68 ANTIGEN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; STAINING; UMBILICAL VEIN;

ACTINS; AGED; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIN-1; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 29144432822     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.09.015     Document Type: Article

References (47)

1. I.N. Holcomb, R.C. Kabakoff, B. Chan, T.W. Baker, A. Gurney, and W. Henzel FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO J 19 2000 4046 4055
2. C.M. Steppan, E.J. Brown, C.M. Wright, S. Bhat, R.R. Banerjee, and C.Y. Dai A family of tissue-specific resistin-like molecules Proc Natl Acad Sci U S A 98 2001 502 506
3. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, and C.M. Wright The hormone resistin links obesity to diabetes Nature 409 2001 307 312
4. E.D. Muse, S. Obici, S. Bhanot, B.P. Monia, R.A. McKay, and M.W. Rajala Role of resistin in diet-induced hepatic insulin resistance J Clin Invest 114 2004 232 239
5. M.W. Rajala, S. Obici, P.E. Scherer, and L. Rossetti Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production J Clin Invest 111 2003 225 230
6. R.R. Banerjee, S.M. Rangwala, J.S. Shapiro, A.S. Rich, B. Rhoades, and Y. Qi Regulation of fasted blood glucose by resistin Science 303 2004 1195 1198
7. D.B. Savage, C.P. Sewter, E.S. Klenk, D.G. Segal, A. Vidal-Puig, and R.V. Considine Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans Diabetes 50 2001 2199 2202
8. R.Z. Yang, Q. Huang, A. Xu, J.C. McLenithan, J.A. Eisen, and A.R. Shuldiner Comparative studies of resistin expression and phylogenomics in human and mouse Biochem Biophys Res Commun 310 2003 927 935
9. L. Patel, A.C. Buckels, I.J. Kinghorn, P.R. Murdock, J.D. Holbrook, and C. Plumpton Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem Biophys Res Commun 300 2003 472 476
10. I. Nagaev, and U. Smith Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle Biochem Biophys Res Commun 285 2001 561 564
11. S. Verma, S.H. Li, C.H. Wang, P.W. Fedak, R.K. Li, and R.D. Weisel Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction Circulation 108 2003 736 740
12. D. Kawanami, K. Maemura, N. Takeda, T. Harada, T. Nojiri, and Y. Imai Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions Biochem Biophys Res Commun 314 2004 415 419
13. P. Calabro, I. Samudio, J.T. Willerson, and E.T. Yeh Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways Circulation 110 2004 3335 3340
14. M. Bajaj, S. Suraamornkul, S. Kashyap, K. Cusi, L. Mandarino, and R.A. DeFronzo Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes J Clin Endocrinol Metab 89 2004 4649 4655
15. J.H. Lee, J.L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, and R. Seip Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects J Clin Endocrinol Metab 88 2003 4848 4856
16. G. Valsamakis, P.G. McTernan, R. Chetty, N. Al Daghri, A. Field, and W. Hanif Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines Metabolism 53 2004 430 434
17. J. Vendrell, M. Broch, N. Vilarrasa, A. Molina, J.M. Gomez, and C. Gutierrez Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity Obes Res 12 2004 962 971
18. Vozarova de Court, M. Degawa-Yamauchi, R.V. Considine, P.A. Tataranni, and Volarova de Court High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians Diabetes 53 2004 1279 1284
19. B.S. Youn, K.Y. Yu, H.J. Park, N.S. Lee, S.S. Min, and M.Y. Youn Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus J Clin Endocrinol Metab 89 2004 150 156
20. D. Stejskal, J. Proskova, S. Adamovska, R. Jurakova, and J. Bartek Preliminary experience with resistin assessment in common population Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 146 2002 47 49
21. A. Sachinidis, M. Flesch, Y. Ko, K. Schror, M. Bohm, and R. Dusing Thromboxane A2 and vascular smooth muscle cell proliferation Hypertension 26 1995 771 780
22. K.A. Pulford, E.M. Rigney, K.J. Micklem, M. Jones, W.P. Stross, and K.C. Gatter KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections J Clin Pathol 42 1989 414 421
23. C. Urbich, E. Dernbach, A.M. Zeiher, and S. Dimmeler Double-edged role of statins in angiogenesis signaling Circ Res 90 2002 737 744
24. M. Tamura, J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K.M. Yamada Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1998 1614 1617
25. J. Plutzky Inflammatory pathways in atherosclerosis and acute coronary syndromes Am J Cardiol 88 2001 10K 15K
26. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
27. R.W. Thompson, P.J. Geraghty, and J.K. Lee Abdominal aortic aneurysms: basic mechanisms and clinical implications Curr Probl Surg 39 2002 110 230
28. M.A. Gimbrone Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis Am J Cardiol 75 1995 67B 70B
29. U. Landmesser, B. Hornig, and H. Drexler Endothelial function: a critical determinant in atherosclerosis? Circulation 109 2004 II27 II33
30. H.C. Fehmann, and J. Heyn Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls Horm Metab Res 34 2002 671 673
31. A. Shalevm, N.B. Patterson, B. Hirshberg, K.I. Rother, and D.M. Harlan Resistin serum levels in type 1 diabetes pre- and post-islet transplantation Metabolism 53 2004 403 404
32. A. Fujinami, H. Obayashi, K. Ohta, T. Ichimura, M. Nishimura, and H. Matsui Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes Clin Chim Acta 339 2004 57 63
33. J.L. Zhang, Y.W. Qin, X. Zheng, J.L. Qiu, and D.J. Zou Serum resistin level in essential hypertension patients with different glucose tolerance Diabet Med 20 2003 828 831
34. P.G. McTernan, F.M. Fisher, G. Valsamakis, R. Chetty, A. Harte, and C.L. McTernan Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes J Clin Endocrinol Metab 88 2003 6098 6106
35. M. Lehrke, M.P. Reilly, S.C. Millington, N. Iqbal, D.J. Rader, and M.A. Lazar An inflammatory cascade leading to hyperresistinemia in humans Plos Med 1 2004 e45
36. A. Sjoholm, and T. Nystrom Endothelial inflammation in insulin resistance Lancet 365 2005 610 612
37. C.C. Wang, M.L. Goalstone, and B. Draznin Molecular mechanisms of insulin resistance that impact cardiovascular biology Diabetes 53 2004 2735 2740
38. J.C. Fruchart, M.C. Nierman, E.S. Stroes, J.J. Kastelein, and P. Duriez New risk factors for atherosclerosis and patient risk assessment Circulation 109 2004 III15 III19
39. S.M. Grundy Obesity, metabolic syndrome, and cardiovascular disease J Clin Endocrinol Metab 89 2004 2595 2600
40. B.J. Goldstein, and R. Scalia Adiponectin: a novel adipokine linking adipocytes and vascular function J Clin Endocrinol Metab 89 2004 2563 2568
41. D.M. Maahs, L.G. Ogden, G.L. Kinney, P. Wadwa, J.K. Snell-Bergeon, and D. Dabelea Low plasma adiponectin levels predict progression of coronary artery calcification Circulation 111 2005 747 753
42. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski Resistin, an adipokine with potent proinflammatory properties J Immunol 174 2005 5789 5795
43. N. Al-Daghri, R. Chetty, P.G. McTernan, K. Al-Rubean, O. Al-Attas, A.F. Jones, and S. Kumar Serum resistin is associated with C-reactive protein and LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population Cardiovasc Diabetol 4 1 2005 10 [Jul 5]
44. G.K. Shetty, P.A. Economides, E.S. Horton, C.S. Mantzoros, and A. Veves Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450 2457
45. M.P. Reilly, M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932 939
46. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, and J. Lee Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 2005 183 190
47. J.J. Diez, P. Iglesias, M.J. Fernandez-Reyes, A. Aguilera, M.A. Bajo, and P. Alvarez-Fidalgo Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease Clin Endocrinol (Oxf) 62 2005 242 249